E-health companies Medlife and PharmEasy have agreed for a merger, according to the filings submitted by the companies to the Competition Commission of India (CCI). The proposed combination relates to the acquisition of 100 per cent equity shares of Medlife by API Holdings, the parent of PharmEasy, in return for 19.59 per cent equity share capital, according to the CCI filing.
Medlife, PharmEasy agree to merge; deal may be valued at over $1 bn
Date posted: Friday 21 August 2020